LGC acquires Technopath Clinical Diagnostics, strengthening its position in clinical quality controls
Complements a wide breadth of existing manufacturing capabilities
Read MoreNews
To contact the press office please email or call +44 7408 850 514
New Wetestyoutrust.com website unifies LGC’s banned-substance testing and certification programs
Enhancements for the Informed Sport (informed-sport.com) and Informed Choice (informed-choice.com) websites include a more robust search functionality allowing users to filter products by regional availability, product type, brand or goal
Read MoreNational Measurement Laboratory at LGC has expanded its portfolio of reference materials
Characterised for sulfur dioxide content traceable to the SI.
Read MoreLGC launches SARS-CoV-2 molecular solution for Oral Fluid Testing
Product designed to support development and testing efforts around novel saliva-based SARS-CoV-2 diagnostics.
Read MoreUFC Recognizes Informed Choice as an Accredited Certification Agency
After an update to their Anti-Doping Policy in 2019, UFC athletes are directed to only use supplements tested and certified by an accredited certification agency.
Read MoreEuan O’Sullivan promoted to President & Chief Operating Officer
President and COO for the group
Read MoreLGC reports half year trading in line with expectations
Management confirms that trading is in line with expectations, with strong momentum expected to continue through the second half of the year to 31 March 2021.
Read MoreLGC acquires SAFEFOOD 360°, expanding its supply chain assurance offering
Safefood 360° supports compliance with major food safety and supplier management requirements
Read MoreStandards for the holiday season: toy safety
Christmas is right around the corner, and with it the promise of toys for children under the tree. Like any consumer product, toys need to be safe and comply with the toy regulation and corresponding toy safety standards.
Read MoreLGC’s Anti-SARS-CoV-2 controls kit now CE Marked
CE mark and IVD symbol signifies that ACCURUN Anti-SARS-CoV-2 Controls Kit meets extensive design control requirements
Read MoreLGC’s high-throughput PCR testing system for SARS-CoV-2 detection, submitted for Emergency Use Authorisation, capable of processing up to 35,000 tests per day
Testing labs can now leverage LGC’s unrivalled expertise in automated sample preparation and high-throughput RT-PCR workflows
Read MoreCinven and Astorg to acquire LGC
Cinven and Astorg have more than 40 years history of investing in and supporting companies to drive value creation and reach their growth potential
Read More